What is the first‑line antibiotic for Prevotella bivia infection in an adult without contraindications?

Antibiotic of Choice for Prevotella bivia

Metronidazole is the first-line antibiotic for Prevotella bivia infection, with 100% susceptibility demonstrated across multiple studies and guideline recommendations for anaerobic coverage. 1, 2, 3

Primary Treatment Recommendation

• Metronidazole demonstrates universal susceptibility against P. bivia isolates, with MIC90 values of 0.5-1 μg/mL, making it the most reliable single agent 2
• All tested P. bivia strains showed susceptibility to metronidazole in multiple surveillance studies across different geographic regions 2, 4, 5
• The Infectious Diseases Society of America guidelines specifically recommend metronidazole for obligate anaerobic bacilli coverage in intra-abdominal and pelvic infections where Prevotella species are commonly encountered 1

Alternative First-Line Options

When metronidazole cannot be used or combination therapy is preferred:

• Beta-lactam/beta-lactamase inhibitor combinations show excellent activity:

  • Piperacillin-tazobactam: 100% susceptibility 4, 5
  • Ampicillin-sulbactam: 99.2% susceptibility (only 0.8% intermediate resistance reported) 5
  • Ticarcillin-clavulanate: recommended for anaerobic coverage 1

• Carbapenems are universally effective but should be reserved for severe or mixed infections:

  • Imipenem and meropenem: 100% susceptibility 4, 5
  • Ertapenem: guideline-recommended for community-acquired infections 1

• Cefoxitin maintains 100% susceptibility and is a suitable alternative 2, 4, 5

Combination Therapy Considerations

For polymicrobial infections (common with P. bivia in pelvic/intra-abdominal infections):

• Ciprofloxacin plus metronidazole is explicitly recommended by IDSA for community-acquired complicated intra-abdominal infections, providing both aerobic gram-negative and anaerobic coverage 6
• Ceftriaxone plus metronidazole is recommended for broader polymicrobial coverage 7

Antibiotics to AVOID

Critical resistance patterns make these agents inappropriate:

• Penicillin and ampicillin: 100% and 97.5% resistance respectively due to universal beta-lactamase production by P. bivia 2
• Clindamycin: 33.7-36.4% non-susceptibility rates make it unreliable without susceptibility testing 4, 5
• Tetracycline: 18-36.8% resistance rates 4, 5
• Moxifloxacin: 16.3-18.3% non-susceptibility 4, 5
• Cefotaxime and ceftriaxone: 30% resistance when used as monotherapy 2

Clinical Context Matters

The infection source determines optimal therapy:

• Gynecologic/pelvic infections (most common P. bivia source): Metronidazole 500 mg IV every 6-8 hours or oral equivalent 6, 3
• Intra-abdominal infections: Combination therapy with ciprofloxacin plus metronidazole for 7-14 days 1, 6
• Septic arthritis or other invasive infections: Metronidazole with surgical drainage is essential for successful outcome 3

Important Caveats

• P. bivia accounts for most multidrug-resistant Prevotella isolates (9.6% resistant to ≥3 antimicrobials), emphasizing the importance of susceptibility testing in treatment failures 4
• Tigecycline shows 100% susceptibility but should be reserved for resistant cases given its broad spectrum 4, 5
• Duration: Treat for 7-14 days for most infections, with longer courses for immunocompromised patients or prosthetic joint infections 1, 6
• Surgical intervention is often necessary alongside antibiotics, particularly for abscesses or septic arthritis 3, 8